ADCETRIS (brentuximab vedotin) is indicated for treatment of patients with Hodgkin lymphoma (HL) after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates. ADCETRIS (brentuximab vedotin) for injection, for intravenous use. Initial U.S. approval: 2011. ADCETRIS (brentuximab vedotin) For Injection should be administered under the supervision of a qualified physician experienced in the uses of cancer chemotherapeutic agents.

Where can I buy Adcetris?

Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its presence PAN India with over 20 years of domain experience.

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Adcetris (brentuximab vedotin) on prescription and Import License in Patient's Name only.

For Adcetris or brentuximab vedotin price in India. Please call at M: +91 9811747774 or Email Us to know more details about the medicine and its cost price in India.
ADCETRIS (brentuximab vedotin)

Get In Touch

Facilitator under Patient Assistance Programs In India

For Indian Patients, doctors and hospitals Adcetris (brentuximab vedotin) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dosage Forms and Strengths

For injection: 50 mg lyophilized powder in a single-use vial (D).

ReadMore

FDA News Release

FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy.
Dated: March 20, 2018

ReadMore